Rare Blood Disorders: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan Kettering’s current clinical trials for rare blood diseases.

Showing 2 trials
Title Investigator
A Phase II Study of AUY922 in Patients with Myelofibrosis
Newly Diagnosed & Relapsed/Refractory
[Protocol 12-076]
Rampal, Raajit, MD
A Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
[Protocol 12-131]
Hyman, David, MD